Borocaptate (sodium )
Product Sizes
5 mg
£ POA
HY-142041-5MG
25 mg
£ POA
HY-142041-25MG
100 mg
£ POA
HY-142041-100MG
50 mg
£ POA
HY-142041-50MG
10 mg
£ POA
HY-142041-10MG
10mM/1mL
£ POA
HY-142041-10MM
About this Product
- SKU:
- HY-142041
- Additional Names:
- BSH
- Application:
- Antibody Microarray
- CAS Number:
- 144885-51-8
- Extra Details:
- Borocaptate sodium is a boron-containing compound that can be used as a therapeutic agent in boron neutron capture therapy (BNCT); exhibiting anticancer activity[1][2].
- Molecular Weight:
- 219.87
- Purity:
- 95.0
- References:
- [1]Bendel P, et al. Optimal detection of the neutron capture therapy agent borocaptate sodium (BSH): A comparison between and NMR[J]. Medical Physics, 2001, 28(2): 178-183.|[2]Kraft SL, et al. Borocaptate sodium: a potential boron delivery compound for boron neutron capture therapy evaluated in dogs with spontaneous intracranial tumors. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11973-7.|[3]Yoshida F, et al. Enhancement of sodium borocaptate (BSH) uptake by tumor cells induced by glutathione depletion and its radiobiological effect. Cancer Lett. 2004 Nov 8;215(1):61-7.|[4]Kokai-Kun J F, et al. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model[J]. Journal of antimicrobial chemotherapy, 2007, 60(5): 1051-1059.
- Research Area:
- Cancer
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -20[o]C (Powder; stored under nitrogen; away from moisture)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Others
